Core Viewpoint - The company, Yipai Yangguang (02522.HK), has announced a placement agreement to issue 35 million shares at a price of HKD 16.76 per share, which represents approximately 13.55% of the existing H-shares and 9.58% of the total issued shares as of the announcement date [1][2]. Group 1 - The placement is expected to raise approximately HKD 586.6 million in total proceeds, with a net amount of about HKD 562.1 million after expenses [2]. - The net proceeds from the placement will be allocated as follows: approximately 40% for the development of data and artificial intelligence in medical imaging, 30% for expanding the medical imaging center business through investments or acquisitions, 20% for establishing an incubation fund for quality healthcare enterprises, and 10% for general working capital [2]. Group 2 - The company aims to deepen its capabilities in data services related to medical imaging by collaborating with leading enterprises in AI and healthcare, as well as major hospitals in China [2]. - The strategic focus includes establishing a data space and creating a convertible imaging center, while also building an investment portfolio in high-quality enterprises within the medical field [2].
一脉阳光(02522.HK)拟配股净筹5.62亿港元 加码医学影像AI与市场扩张